Patent ID: 9662331
Date: 2017-05-30
CPC Classifications: A61K,C07D

Claim:
1. A method of inhibiting a PI3 kinase in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of Formula I: or a pharmaceutically acceptable salt or solvate thereof, wherein X X R X X s, t, and u are each independently selected from 0, 1, 2, 3, 4, 5, 6, and 7; v, w, and x are each independently selected from 0 and 1; R each X X X e, f, and g are each independently selected from 0, 1, 2, 3, 4, 5, 6, and 7; h, i, and j are each independently selected from 0 and 1; and z is selected from 0, 1, and 2, provided that when X provided that R